Investment Thesis
Alphatec demonstrates compelling revenue growth (+25% YoY) and strong gross margins (71%) indicating product-market fit in the medical device sector, but is technically insolvent with negative stockholders equity (-$5.3M) and cannot service its $573.4M debt burden from operations. Negative operating margins (-11.8%), inability to cover interest expenses (-1.9x coverage), and negative free cash flow (-$10.8M) signal the business model has not yet achieved sustainable profitability despite scale.
Strengths
- Strong revenue growth of +25% YoY demonstrates robust market demand and execution
- Exceptional gross margins of 71% indicate strong pricing power and operational efficiency in manufacturing
- Cash position of $139.9M provides 2-3 year operational runway at current burn rates
Risks
- Negative stockholders equity of -$5.3M represents technical insolvency and indicates liabilities exceed assets
- High debt load of $573.4M with negative interest coverage ratio (-1.9x) creates acute refinancing and default risk
- Negative free cash flow of -$10.8M despite positive operating cash flow signals capital intensity outpaces operational cash generation
- Operating losses of -$22.6M and net margin of -17.6% indicate scale is not yet driving profitability
Key Metrics to Watch
- Operating margin trend - must achieve positive margins to justify debt load and equity raise needs
- Free cash flow inflection point - path to positive FCF demonstrates long-term viability
- Debt refinancing activity and covenant status - critical for near-term solvency
- Timeline and trajectory to GAAP profitability - quarterly improvement rate essential for investor confidence
Financial Metrics
Revenue
192.1M
Net Income
-33.9M
EPS (Diluted)
$-0.22
Free Cash Flow
-10.8M
Total Assets
799.5M
Cash
139.9M
Profitability Ratios
Gross Margin
71.0%
Operating Margin
-11.8%
Net Margin
-17.6%
ROE
N/A
ROA
-4.2%
FCF Margin
-5.6%
Balance Sheet & Liquidity
Current Ratio
1.90x
Quick Ratio
1.12x
Debt/Equity
N/A
Debt/Assets
0.0%
Interest Coverage
-1.93x
Long-term Debt
573.4M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-07T08:02:58.839104 |
Data as of: 2026-03-31 |
Powered by Claude AI